[Maternal serum-alpha-fetoprotein for monitoring risk-pregnancies (author's transl)].
This study confirms essentially the results of other investigators who found a good correlation between fetal risk and maternal AFP level. This adds an immuno-chemical technique to well-known methods of monitoring risk-pregnancies (ultra-sound, HPL, estrogenes) which enables us to measure a specific fetal metabolic product, alpha-feto-protein, in amniotic fluid, umbilical blood and maternal serum.
D000030:Abortion, Missed; D000653:Amniotic Fluid / Q000032:analysis; D005260:Female; D005312:Fetal Blood; D005313:Fetal Death; D005326:Fetal Proteins / Q000032:analysis*; D005333:Fetus; D006801:Humans; D010927:Placental Insufficiency / Q000378:metabolism; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000378:metabolism*; D011272:Pregnancy, Multiple; D000509:alpha-Fetoproteins / Q000032:analysis*
D005326:Fetal Proteins; D000509:alpha-Fetoproteins
Maternes Serum-Alpha-Fetoprotein zur Uberwachung der Risikoschwangerschaft